Mediastinal small cell cancer associated with Lambert-Eaton myasthenic syndrome: A case report

Zhang,Kejian; Liu,Wei; Li,Yang; Zhang,Kewei; Gao,Xinliang; Wang,Jing

doi:10.3892/etm.2015.2454

July-2015 Volume 10 Issue 1

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

July-2015 Volume 10 Issue 1

Full Size Image

Case Report

Mediastinal small cell cancer associated with Lambert-Eaton myasthenic syndrome: A case report

Authors:
- Kejian Zhang
- Wei Liu
- Yang Li
- Kewei Zhang
- Xinliang Gao
- Jing Wang
View Affiliations / Copyright

Affiliations: Department of General Thoracic Surgery, Bethune Chest Center, Bethune First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China
Pages: 117-120
|
Published online on: April 27, 2015

https://doi.org/10.3892/etm.2015.2454
Expand metrics +

Abstract

Lambert-Eaton myasthenic syndrome (LEMS) is typically characterized as a paraneoplastic syndrome associated with small cell lung carcinoma. The presence of LEMS in association with other neuroendocrine lung tumors, including carcinoids or large cell lung carcinoma, is highly unusual. The present case study reports the very rare case of a patient with mediastinal small cell cancer combined with LEMS. A 53‑year‑old man was admitted to the Bethune First Hospital with a 3‑month history of weakness in the lower extremities that had become aggravated during the previous 20 days. A positron emission tomography‑computed tomography (CT) examination demonstrated multiple enlarged, hypermetabolic lymph nodes between the vena cava and trachea, indicating the presence of inflammation. No other abnormalities were identified. A mediastinal lymph node biopsy revealed a high prevalence of small cell neuroendocrine carcinoma. The immunohistochemistry results were as follows: Ki‑67 (+50, meaning that 50% of the cells exhibited Ki‑67 expression), cytokeratin (CK; +), cluster of differentiation (CD)56 (+), synaptophysin (+), thyroid transcriptional factor‑1 (+), epithelial membrane antigen (+), neuron‑specific enolase (+), P63 (weakly +), leukocyte common antigen (‑), CD99 (‑), vimentin (‑) and CK5/6 (‑). Following a diagnosis of LEMS, the patient underwent one course of cisplatin + etoposide chemotherapy, which was ineffective. Subsequently, the patient underwent a different chemotherapy regimen (cisplatin + etoposide + ifosfamide), which significantly improved the symptoms of myasthenia. Following completion of this treatment regimen, the primary lesion was not observed on a lung CT scan, and the mediastinal lymph nodes had clearly diminished. Subsequently, the patient underwent two courses of radiotherapy (40 Gy/22f/6W).

View Figures

View References

1	Lee JH, Shin JH, Kim DS, et al: A case of Lambert-Eaton myasthenic syndrome associated with atypical bronchopulmonary carcinoid tumor. J Korean Med Sci. 19:753–755. 2004. View Article : Google Scholar : PubMed/NCBI
2	Gilhus NE: Myasthenia and the neuromuscular junction. Curr Opin Neurol. 25:523–529. 2012. View Article : Google Scholar : PubMed/NCBI
3	Tomiyasu K, Ito H, Kanazawa N, Saito T and Kowa H: Anti-Hu antibody in a patient with Lambert-Eaton myasthenic syndrome and early detection of small cell lung cancer. Intern Med. 34:1082–1085. 1995. View Article : Google Scholar : PubMed/NCBI
4	LoMonaco M, Milone M, Padua L and Tonali P: Combined low-rate nerve stimulation and maximal voluntary contraction in the detection of compound muscle action potential facilitation in Lambert-Eaton myasthenic syndrome. Muscle Nerve. 20:1207–1208. 1997. View Article : Google Scholar : PubMed/NCBI
5	Titulaer MJ, Lang B and Verschuuren JJ: Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol. 10:1098–1107. 2011. View Article : Google Scholar : PubMed/NCBI
6	Martín-García E, Mannara F, Gutiérrez-Cuesta J, et al: Intrathecal injection of P/Q type voltage-gated calcium channel antibodies from paraneoplastic cerebellar degeneration cause ataxia in mice. J Neuroimmunol. 261:53–59. 2013. View Article : Google Scholar : PubMed/NCBI
7	Wu X, Wang J, Liu Y and Liu K: Clinical presentation and differential diagnosis of Lambert-Eaton myasthenic syndrome. Neurosciences (Riyadh). 18:169–172. 2013.PubMed/NCBI
8	Nakamur S, Kawagishi Y, Kato S, et al: Long-term survival case of small-cell lung cancer with Lambert-Eaton myasthenic syndrome without anticancer therapy. Nihon Kokyuki Gakkai Zasshi. 48:918–922. 2010.(In Japanese). PubMed/NCBI
9	Baggi F, Ubiali F, Nava S, et al: Effect of IgG immunoadsorption on serum cytokines in MG and LEMS patients. J Neuroimmunol. 201–202:104–110. 2008. View Article : Google Scholar : PubMed/NCBI
10	Tsukiji J, Kaneko T, Saito H, et al: A case of cT0N2M0 small cell lung cancer with Lambert-Eaton myasthenic syndrome. Nihon Kokyuki Gakkai Zasshi. 42:820–824. 2004.(In Japanese). PubMed/NCBI
11	Oh SJ, Kurokawa K, Claussen GC and Ryan HF Jr: Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome. Muscle Nerve. 32:515–520. 2005. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Mediastinal small cell cancer associated with Lambert-Eaton myasthenic syndrome: A case report

This article is mentioned in:

Abstract

Figure 1

Figure 2

Related Articles